ELIZABETH J TAPE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SEYMOUR, IN NPI 1275905986
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IN Novo Nordisk AS All categories
General Payments — all program years on this page
$7,586.36
- Category: General Payments
- Program years: PY2021–2024
- Record count: 477
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,842.41 across 100 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,842.41 | 100 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $349.25 | 20 |
| Lilly USA, LLC | $238.48 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $203.96 | 13 |
| ABBVIE INC. | $146.35 | 10 |
| Insulet Corporation | $140.24 | 9 |
| CeQur Corporation | $133.13 | 1 |
| Corcept Therapeutics | $75.27 | 4 |
| ARGENX US, INC. | $73.58 | 3 |
| Xeris Pharmaceuticals, Inc. | $68.65 | 3 |
| Radius Health, Inc. | $67.29 | 4 |
| SANOFI-AVENTIS U.S. LLC | $53.22 | 2 |
| DEXCOM, INC. | $52.25 | 2 |
| Amgen Inc. | $51.24 | 3 |
| Medtronic, Inc. | $43.34 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $25.25 | 1 |
| Neurelis, Inc. | $23.99 | 1 |
| Neurocrine BioSciences, Inc. | $18.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.52 | 1 |
| Tandem Diabetes Care, Inc. | $16.10 | 1 |
| Esperion Therapeutics, Inc. | $15.22 | 1 |
| SCILEX PHARMACEUTICALS INC. | $14.87 | 1 |
| Abbott Laboratories | $14.23 | 1 |
By program year
Records — PY2024 (100)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.